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Abstract
Background: Green tea is widely consumed in Asian countries and is becoming increasingly
popular in Western countries. Epidemiologically, it has been suggested that green tea consumption
prevents type 2 diabetes. The present study was aimed at providing evidence of improvement in
glucose metabolism in diabetic mice and healthy humans upon green tea consumption.
Results: Green tea promoted glucose metabolism in healthy human volunteers at 1.5 g/body in
oral glucose tolerance tests. Green tea also lowered blood glucose levels in diabetic db+/db+ mice
and streptozotocin-diabetic mice 2–6 h after administration at 300 mg/kg without affecting serum
insulin level, whereas no effect was observed in control mice (+m/+m and normal ddY mice). The
serum protein profiles of db+/db+ and +m/+m mice were analyzed for the first time by SELDI
(surface-enhanced laser desorption/ionization)-TOF (time-of-flight)-MS (mass spectrometry), and
then compared to investigate any effects of oral green tea administration on serum proteins. The
protein profiles in db+/db+ mice showed that the spectral peak intensities at the mass/charge ratios
(m/z) of 4119, 4203, 4206, 4211, 4579, 9311 and 18691 were >3 times lower, and those of 13075,
17406, 17407, 17418, 17622, 18431 and 26100 were >3 times higher than respective peak
intensities in +m/+m mice. When green tea was administered to db+/db+ mice, the peak intensities
were markedly decreased at m/z 11651 and 11863, and slightly decreased at m/z 4212. The peak
intensities at 7495, 7595, 7808, 14983, 15614, 31204 were markedly increased after the
administration.
Conclusion:  The present study provides evidence that green tea has an antidiabetic effect.
Although we could not find simple reversed effect of green tea on the diabetes-induced
modifications of the levels of several serum proteins, we found that the 4211 (4212) Da protein
level that was decreased in the diabetic state was further decreased after green tea administration.
This is the first report demonstrating that a certain serum protein may be involved in the
antihyperglycemic effect of green tea. The contribution of this protein should be further studied.
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Background
Green tea (leaves of Camellia sinensis, Theaceae) is a pop-
ular beverage in East Asia, and also used as a herbal rem-
edy in Europe and North America. Green tea is considered
to be antiinflammatory, antioxidative, antimutagenic,
and anticarcinogenic [1,2], and can prevent cardiac disor-
ders. Epidemiologically, it has been suggested that green
tea consumption prevents type 2 diabetes. The ameliora-
tion of insulin resistance by green tea is associated with
the increased expression level of glucose transporter IV in
a fructose-fed rat [3]. Green tea extract contains polyphe-
nols (e.g., catechin, epicatechin, epigallocatechin, and
their gallates), teanin and caffeine. The extract also
includes pyrroloquinoline quinone, a newly discovered
vitamin [4]. Some constituent components have been
shown to enhance the basal and insulin-stimulated glu-
cose uptake of rat adipocytes [5], to inhibit intestinal glu-
cose uptake by inhibiting the sodium-dependent glucose
transporter of rabbit intestinal epithelial cells [6], and to
reduce serum glucose level in alloxan-diabetic rats [7].
Controversially, caffeine acutely lowers insulin sensitivity
in humans [8].
The present study was aimed at providing evidence of the
improvement in glucose metabolism in humans and dia-
betic mice upon green tea consumption. Furthermore, to
investigate whether some serum proteins mediate the
effects of green tea on hyperglycemia in the diabetic state,
proteomic analyses were performed using SELDI (surface
enhanced laser desorption/ionization)-TOF (time-of-
flight)-MS (mass spectrometry), because the SELDI-TOF-
MS enables the measurement of the relative abundance of
proteins of various sizes in a blood sample. Here, we com-
pared the proteomic patterns of sera from diabetic db+/
db+ and wild-type mice, and further investigated the
influence of green tea administration on the proteomic
patterns of serum in diabetic mice. If the diabetic modifi-
cations of serum protein levels are reversed by green tea
administration, these affected proteins can be used as
therapeutic targets in diabetes.
Results
Oral glucose tolerance test (OGTT)
We investigated whether oral glucose tolerance is
improved in healthy volunteers by drinking a suspension
of green tea powder. Blood glucose levels were measured
before and 30, 60, and 120 min after drinking 1.5 g of
green tea. The effects of hot water without tea powder on
blood glucose level in the same participants were also
investigated. Fig. 1 shows that glucose tolerance was sub-
stantially improved with tea administration compared
with hot water administration. In detail, glucose metabo-
lism increased in 14 participants, remained unchanged in
3 participants, and worsened in 5 participants. Basal
blood glucose levels (BGLs) did not significantly change
in all participants (Fig. 1).
Antihyperglycemic effects of green tea in diabetic mice
The crude extract of fresh tea leaves picked from either
No.12 or No. 13 cultivar at 300 mg/kg significantly low-
ered BGL 2–6 h after peroral administration in streptozo-
tocin (STZ)-diabetic ddY mice in the fasting state (Fig. 2).
In the saline-treated control group (n = 5), BGL slightly
changed from 273 ± 28 mg/dl to 241 ± 28 mg/dl after 6 h,
whereas in the green-tea (No. 12)-treated group (n = 3),
BGL markedly changed from 235 ± 15 mg/dl to 116 ± 12
mg/dl. Similarly, BGL markedly changed from 201 ± 10
mg/dl to106 ± 8 mg/dl after 6 h in the green-tea (No. 13)-
treated group (n = 3).
The antihyperglycemic effects of green tea powder suspen-
sion at 30, 150, and 300 mg/kg were examined 2 h after
administration to the STZ-diabetic mice in the fasting
state. As shown in Fig. 3, green tea tended to lower BGL at
Increase in glucose metabolism in healthy humans adminis- tered with green tea Figure 1
Increase in glucose metabolism in healthy humans 
administered with green tea. Oral glucose tolerance 
curves (OGTT, n = 22) and basal blood glucose levels (Basal, 
n = 25) before and 30, 60 and 120 min after administration 
with either a suspension of green tea powder (● ) or hot 
water (❍ ). All participants were fasted since the last supper 
before starting the experiment at 9:30 a.m. In the glucose tol-
erance test, 225 ml of Trelan-G75 containing 75 g glucose 
was perorally administered 10 min after drinking a suspen-
sion of green tea powder (1.5 g/150 ml hot water) or hot 
water (150 ml). Effect of green tea or hot water on basal 
blood glucose levels was examined without administrating 
Trelan-G75. Blood glucose levels (mg/dl) measured were 
averaged in each treatment group, and compared by cross-
over test. Values represent the means ± S.E.M. *P < 0.05, **P 
< 0.01; significantly different from the vehicle control at each 
time-point, determined by one-way ANOVA, followed by 
Scheffé's test.
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150 mg/kg, and significantly lowered BGL at 300 mg/kg.
Furthermore, the effect of green tea was compared among
different groups of mice, i.e., STZ-diabetic ddY mice, nor-
mal ddY mice, diabetic db+/db+ mice and +m/+m mice
(Fig. 4). BGLs were significantly lowered in both STZ-dia-
betic mice and db+/db+ mice 2 h after administration of
green tea powder suspension (300 mg/kg), whereas no
significant changes were observed in normal ddY mice
and +m/+m mice.
No elevation of blood insulin levels was observed during
the decrease in BGL either by tea leaf extract or by green
tea suspension in STZ-diabetic mice (data not shown).
These results suggest that both fresh green tea leaf extract
and green tea suspension lower BGL without changing
serum insulin concentration.
Serum protein profiles altered in diabetic db+/db+ mice
To explore the mechanisms underlying the antihyperglyc-
emic effect of green tea, proteomic patterns of sera from
diabetic (db+/db+) and wild-type (+m/+m) mice were
first investigated and compared to identify peaks specific
to the diabetic state using SELDI-TOF-MS. Samples of sera
from fasting +m/+m mice were loaded onto CM10 (a cat-
ionic exchanger, pH4) ProteinChip arrays (Fig. 5). The
other types of ProteinChip Array, i.e., CM10 (a cationic
exchanger, pH7), Q10 (an anionic exchanger, pH8) and
IMAC30-Cu2+ (immobilized metal affinity chromatogra-
phy, pH7), were also used to fractionate proteins in the
serum. Then, these arrays were analyzed using a Protein-
Chip system, and the amount of individual serum pro-
teins was estimated from the peak intensity of the mass
spectral signal and the mass/charge ratio (m/z) equivalent
to the molecular weight of each protein. All the spectral
peaks of serum proteins from diabetic mice, which were
significantly different (P < 0.05, by unpaired t-test) in
intensities from those of serum proteins from wild-type
mice, are shown in Fig. 6A: the peak intensities of proteins
at m/z 4119, 4203, 4206, 4211, 4579, 9311 and 18691
were >3 times lower, and those at m/z 13075, 17406,
17407, 17418, 17622, 18431, 26100 were >3 times
higher than respective peak intensities of proteins of sera
from +m/+m mice. Typical spectra are shown in Figs. 6B
and 6C (see additional file 1 concerning the other peaks).
Antihyperglycemic effects of green tea leaf extracts in the  fasting STZ-diabetic ddY mice Figure 2
Antihyperglycemic effects of green tea leaf extracts 
in the fasting STZ-diabetic ddY mice. The dried 
extracts of fresh tea leaves prepared at the Taiwan Tea 
Experiment Station [TTES, Cultivar No. 12 (Chinhsuan) and 
No.13 (Tzuiyu)] were dissolved in saline and perorally admin-
istered at 300 mg/kg into STZ-diabetic ddY mice in the fast-
ing state. Blood glucose levels 2 h, 4 h, and 6 h after 
administration of green tea leaf extracts are expressed as 
percentages of the glucose levels at 0 h (before the adminis-
tration) in each mouse, and then averaged. Values represent 
the means ± S.E.M. (n = 3–5). *P < 0.05; significantly different 
from the blood glucose levels of STZ-diabetic mice adminis-
tered with saline (control) at each time-point, determined by 
one-way ANOVA, followed by Scheffé's test.
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Antihyperglycemic effects of green tea powder suspension in  the fasting STZ-diabetic ddY mice Figure 3
Antihyperglycemic effects of green tea powder sus-
pension in the fasting STZ-diabetic ddY mice. STZ-
diabetic ddY mice were perorally administered with a sus-
pension of green tea powder at 30, 150, and 300 mg/kg in the 
fasting state. Blood glucose levels 2 h after the administration 
of green tea are expressed as percentages of the glucose 
level 0 h before the administration in each mouse, and then 
averaged. Values represent the means ± S.E.M. (n = 6 – 20). 
**P < 0.01; significantly different from the blood glucose lev-
els of STZ-diabetic mice administered with saline (control, 0 
mg/kg of green tea), by one-way ANOVA, followed by 
Scheffé's test.
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Modification of serum protein profiles of diabetic db+/db+ 
mice by green tea
Serum protein profiles of db+/db+ mice were investigated
2 h after green tea administration, and compared with
those administered with saline (control). Again, we con-
firmed a significant decrease in BGL by green tea in the
blood samples used in these proteomic analyses (data not
shown). All the protein signals that were significantly
changed (P < 0.05, by unpaired t-test) in terms of peak
intensity by the green tea administration, but not by the
saline administration, are described in Fig. 7A. The serum
proteomic patterns of the green-tea-treated group demon-
strate that the peak intensities of proteins at m/z 11651
and 11863 decreased to less than one third after 2 h of tea
administration, whereas no significant changes were
observed in the control group. Typical spectra are shown
in Fig. 7B (see additional file 2 for the change at m/z
11651). When the results in Fig. 7A are compared with
those in Fig. 6A to identify protein peaks specific for dia-
betes and which are sensitive to green tea administration,
a peak at m/z 4211 (4212) was found (Fig. 8). The
intensity of this peak was significantly lowered in the dia-
betic state (Fig. 8A), and was significantly decreased 2 h
after green tea administration (Fig. 8B).
The relative peak intensities of hemoglobin-related mult-
isignals ranging from m/z 14974 to 15638 [9] were
increased by green tea administration (Fig. 7A). Parallel
changes were observed at half and double these m/z val-
ues (Fig. 7A, 9) (see additional file 2 concerning these
changes). Since multicharged protein ions are apparently
observed as proteins of different sizes in the mass spec-
trometry, these changes seem to reflect the modification
of one group of proteins (hemoglobin-related proteins)
by green tea intake.
Discussion
Green tea is widely consumed in Asian countries, while
black tea is most popular in Western countries. The man-
ufacturing process of green tea differs from that of black
tea because freshly picked young leaves of the tea are
immediately steamed. This process destroys the enzymes
responsible for breaking down the color pigments in the
leaves and allows the tea to maintain its green color dur-
ing the subsequent rolling and drying processes. The
amounts of constituent compounds are slightly different
from those of black tea. Pharmacological studies using
Blood-glucose-lowering effects of green tea in diabetic mice  but not in normal mice Figure 4
Blood-glucose-lowering effects of green tea in dia-
betic mice but not in normal mice. STZ-diabetic ddY, 
normal ddY, diabetic db+/db+, and wild-type (+m/+m) mice 
were perorally administered with either a suspension of 
green tea powder at 300 mg/kg or saline in the fasting state. 
Blood glucose levels (mg/dl) were measured before and 2 h 
after the administration, and then averaged. Values represent 
the means ± S.E.M. (n = 5 – 21). *P < 0.05, **P < 0.01; signifi-
cantly different from values at 0 h (before the administra-
tion), by one-way ANOVA, followed by Scheffé's test.
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Analysis of proteomic profiles in mouse serum using SELDI- TOF-MS Figure 5
Analysis of proteomic profiles in mouse serum using 
SELDI-TOF-MS. Serum samples from fasting wild-type 
(+m/+m) mice were loaded onto the spots of CM10 (a cati-
onic exchanger, pH4) ProteinChip arrays. The spots were 
analyzed using the SELDI ProteinChip system on three differ-
ent ranges: m/z 3000 – 10000, m/z 10000 – 20000 and m/z 
20000 – 100000. The y-axis of the spectra indicates the 
mass-to-charge ratio (m/z) of protonated proteins, and the x-
axis indicates the relative intensities of mass spectral signals. 
Note: The intensity of each peak is directly proportional to 
the amount of protein, but the peak intensities could not be 
comparable among the different proteins because of the dif-
ference in ionization.
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Proteomic analyses demonstrating the differences in protein  profiles of sera from diabetic and wild-type mice Figure 6
Proteomic analyses demonstrating the differences in 
protein profiles of sera from diabetic and wild-type 
mice. Serum samples from fasting diabetic (db+/db+) mice 
and fasting wild-type (+m/+m) mice were loaded onto Pro-
teinChip arrays. (A) List of peaks of proteins and/or peptides 
with indicated m/z values, the peak intensities of which were 
significantly changed in the diabetic state. Relative peak inten-
sities were averaged (n = 8). The fold changes are presented 
as ratios of the peak intensities at indicated m/z values in 
db+/db+ to those in the +m/+m mice. Peaks at m/z 4203, 
4576, 8515, 9291, 17406 and 18678 were obtained using 
CM10 ProteinChip (pH4). Peaks at 8733 and 9311 m/z were 
obtained using CM10 ProteinChip (pH7). Peaks at m/z 3933, 
4119, 4206, 4369, 4566, 4579, 4637, 8523, 8827, 8915, 9283, 
13075, 17407, 17418, 17622, 18431, 18691, 22334 and 
26100 were obtained using Q10 ProteinChip. Peak at m/z 
4211 was obtained using IMAC30. The chips were analyzed 
by SELDI-TOF-MS. (B) and (C) Typical data of relative peak 
intensities in +m/+m and db+/db+ mouse sera (upper, repre-
sentative of 4–8 independent observations) and the peak 
intensity averages at m/z 4206 and 26100 (lower, n = 4 for 
+m/+m, n = 8 for db+/db+). The analyzed peak is indicated 
by arrows in the data of mass spectral signals. **P < 0.01; sig-
nificantly different from the peak in wild-type mice, by 
unpaired t-test.
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Changes in serum protein profiles in db+/db+ mice by admin- istration of green tea Figure 7
Changes in serum protein profiles in db+/db+ mice by 
administration of green tea. Serum samples from fasting 
diabetic (db+/db+) mice 2 h after administration of green tea 
suspension were loaded onto ProteinChip Arrays. The chips 
were analyzed using SELDI-TOF-MS. (A) List of peaks of 
proteins and/or peptides with indicated m/z values, the peak 
intensities of which were significantly changed by the green 
tea administration. Relative peak intensities were averaged (n 
= 4). The fold changes are presented as ratios of the peak 
intensities at indicated m/z values 2 h after to before green 
tea administration. Peaks at m/z 7495, 7595, 7808, 7920, 
14983, 15612 and 15614 were obtained using CM10 Protein-
Chip (pH4), whereas those at m/z 7503, 7611, 7823, 7926, 
11651, 11664, 11863, 15004 and 15638 were obtained using 
CM10 ProteinChip (pH7). Peaks at m/z 4212, 4226, 7499, 
11637, 11846, 13711, 13831, 14974, 15180, 31204 and 
65906 were obtained using IMAC30 ProteinChip. (B) Typical 
data of relative peak intensities (upper, representative of 4 
independent observations) and the peak intensity average at 
m/z 11863 (lower, n = 4) after green tea administration and 
saline control. The analyzed peak is indicated by arrows in 
the data of mass spectral signals. **P < 0.01; significantly dif-
ferent from the peak obtained before the administration, by 
unpaired t-test.
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constituent compounds in green tea have been recently
reviewed by Kaszkin et al. [10]. Green tea extracts are more
stable than pure epigallocatechin gallate, the major
constituents of green tea, because of the presence of other
antioxidant constituents in the extract [10]. In general,
herbal medicines are complex mixtures of different com-
pounds that often act in a synergistic fashion and exert
their full beneficial effect as total extracts [11].
In the present study, we demonstrated that green tea pro-
duces an antihyperglycemic effect without affecting insu-
lin secretion in STZ-diabetic mice. We therefore explore
the mechanism underlying the green tea effect by
investigating the serum protein profiles of db+/db+ mice,
a genetic model of type 2 diabetes, using SELDI-TOF-MS.
First, we performed a preliminary analysis to determine
the peaks (molecular weights) of biomarker proteins that
were abnormally contained in the serum of diabetic mice,
without identifying individual serum proteins. As a result,
we found that the levels of several serum proteins were
significantly altered in the diabetic state. Secondly, we
investigated which marker proteins are affected by green
tea administration. Despite the changes in the levels of
several serum proteins after green tea administration,
none of the protein peaks specific for diabetes were sensi-
tive to the administration, except for a peak at m/z
4211(4212). The level of this 4211(4212) Da protein was
reduced both in the diabetic state and by green tea
Changes in peak intensity at m/z 4211 in diabetic state and  after green tea administration Figure 8
Changes in peak intensity at m/z 4211 in diabetic 
state and after green tea administration. (A) Decrease 
in the peak intensity at m/z 4211 in serum samples from fast-
ing diabetic (db+/db+) mice, compared with that of the fast-
ing wild-type (+m/+m) mice. Typical data of relative peak 
intensities in +m/+m and db+/db+ mouse sera (upper, repre-
sentative of 4–8 independent observations) and the averaged 
intensities of the peak at m/z 4211 (lower, n = 4 for +m/+m, 
n = 8 for db+/db+) indicated above by arrows. **P < 0.01; 
significantly different from the peak in wild-type mice, by 
unpaired t-test. (B) Decrease in the peak intensity at m/z 
4212 in serum samples from fasting db+/db+ mice 2 h after 
green tea administration. Typical data of relative peak inten-
sity (upper, representative of 4 independent observations) 
and the averaged intensities of the peak at m/z 4212 (lower, 
n = 4) after administration with either green tea or saline. 
**P < 0.01; significantly different from the peak obtained 
before the administration, by unpaired t-test.
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Hemoglobin-related multiple SELDI-TOF-MS signals in db+/ db+ mice Figure 9
Hemoglobin-related multiple SELDI-TOF-MS signals 
in db+/db+ mice. Samples of sera from nontreated db+/
db+ mice in the fasting state were loaded onto ProteinChip 
arrays. Left panel: hemoglobin-related multi-MS signals. From 
the average of 8 data, the signals were detected from m/z 
14974 to 15638 (+H) using CM10 ProteinChip (pH7). The 
double-charged m/z values appear to be observed from m/z 
7495 to 7823 (+2H). These values may correspond to hemo-
globin α- and β-chains, and other hemoglobin-related pro-
teins. Right panel: multi-MS signals observed at approximately 
double the single-charged m/z values for the hemoglobin-
related signals, using IMAC ProteinChip. These signals may 
correspond to the dimers of hemoglobin α- and β-chains.
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administration. Thus, no simple reversed effect of green
tea on the diabetes-induced modifications of serum pro-
tein levels was observed.
The 4211(4212) Da protein has not yet been identified,
but only two candidate groups of vertebrate proteins are
found by scanning Swiss-Prot database (molecular
weight, 4211; molecular weight ranges, 0.1% according to
the standard errors of the current MS analysis; pI, 6; pI
ranges, 10): pancreatic polypeptide (PP) (primary acces-
sion numbers P13083, P37999, P41519, P38000,
P11967) and antibacterial peptides [β-defensin C7
precursor (018815), 4 kDa defensin (P56686), crypti-
dine-5 precursor (P28312), antibacterial peptide BMAP-
34 precursor (P56425)]. PP is primarily expressed in the
endocrine cells of the pancreas, and the plasma PP con-
centrations are elevated by food intake [12]. Peripheral PP
administration results in a reduction in food intake and
an increase in energy expenditure [12]. Interestingly, a
previous study revealed that PP-containing cell
populations in the islets of Langerhans are reduced in
db+/db+ mice with mild hyperinsulinemic diabetes [13],
which is consistent with the observed reduction in the
intensity of the peak at m/z 4211(4212) in the diabetic
state. We speculate that the reduction of BGL by green tea
causes a decrease in serum PP concentrations as a means
of maintaining energy homeostasis, although more pre-
cise studies are required.
The changes in serum protein profiles by green tea also
demonstrate the increase in the peak intensities of hemo-
globin-related multi-MS signals, suggesting the adverse
side effects of green tea, although blood samples from
db+/db+ mice tended to exhibit a hemolytic feature com-
pared with those from wild-type mice (data not shown).
Interestingly, the hemoglobin-related multi-MS signals
shown in Fig. 9 may include hemoglobin α-chains and β-
chains [9], their dimers, and possibly variously glycated
hemoglobins. Hemoglobin A1c is used as a marker of dia-
betes in clinical diagnostic tests. Until now, however, the
extent of glycation per hemoglobin that practically
occurred is not clear. More detailed analyses of serum
protein profiles using SELDI-TOF-MS will provide a more
useful clinical index of the diabetic state.
We observed that green tea improved oral glucose toler-
ance in humans. It is therefore likely that green tea is pro-
phylactic against diabetes and ameliorates diabetic
hyperglycemia. Green tea consumption at moderate doses
may be associated with a reduced risk of type 2 diabetes in
apparently healthy individuals by controlling postpran-
dial hyperglycemia.
Conclusions
The control of postprandial hyperglycemia by green tea
can help reduce the risk of type 2 diabetes. In the present
study, we provide evidence showing that green tea pro-
motes glucose metabolism in healthy humans, and
produces an antihyperglycemic effect in diabetic mice. In
addition, we analyzed the serum protein profiles of db+/
db+ and +m/+m mice for the first time using SELDI-TOF-
MS, and further investigated its association with any
effects of oral green tea administration on serum proteins.
Among the several proteins that were significantly low-
ered in the serum of diabetic mice, the 4211(4212) Da
protein was significantly decreased after green tea admin-
istration. This is the first report demonstrating that a cer-
tain serum protein is involved in the antihyperglycemic
effect of green tea. The contribution of this protein, there-
fore, should be further investigated in a future study.
Moreover, we speculate that the observed effects of green
tea on BGL are primarily due to the promotion of insulin
action in peripheral tissues, such as skeletal muscles and
adipocytes. Indeed, a recent paper showed that green tea
supplementation for 12 weeks ameliorates insulin resist-
ance and increases glucose transporter IV content in a fruc-
tose-fed rat model resembling the human type 2 diabetes
mellitus [3]. Since the administration of green tea pro-
duced an acute antihyperglycemic effect on BGL in dia-
betic mice in the present study, additional mechanisms,
such as changes in amelioration or enhancement of insu-
lin action, should be clarified in a future study. To eluci-
date whether new protein synthesis is required for green
tea action, it would be useful to examine the influence of
protein synthesis inhibitors on the acute antihyperglyc-
emic effect of green tea.
Methods
Housing and care of animals
C57BLKS/J db+/db+ mice (male, 9 – 11 weeks old, 36.2 –
46.3 g, BGL: 243–411 mg/dl) and its age-matched control
C57BLKS/J +m/+m mice (male, 20.6–23.9 g, BGL: 110–
185 mg/dl) were purchased from SLC (Shizuoka, Japan)
and used as the type 2 diabetic mouse model. Male ddY
mice (4 weeks old, purchased from SLC, Shizuoka, Japan)
were singly injected with STZ (150 mg/kg, i.v.), and then
used 4–6 weeks after the injection (28.8–38.5 g, BGL:
247–600 mg/dl). The age-matched normal ddY mice
(34.7–38.6 g, BGL: 129–197 mg/dl) were also used. The
animals were housed (3–5 per cage) under a daily cycle of
12 h light and 12 h darkness, with free access to food and
water. Animals were treated as approved by the Toyama
Medical and Pharmaceutical University Animal Research
Committee, and according to the guidelines for animal
experiments established by the Japanese Pharmacological
Society.BMC Pharmacology 2004, 4:18 http://www.biomedcentral.com/1471-2210/4/18
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Sampling of blood
Mice were deprived of food for 11–14 h. Blood samples
(20 µl) were collected from mouse tail veins under ether
anesthesia. In experiments for proteomic analyses and
serum insulin measurements, blood samples (100 µl)
were collected from the orbital venous plexus of mice
under ether anesthesia. The food deprivation was contin-
ued throughout the measurement of blood glucose levels
(until 6 h after the administration with green tea). In the
oral glucose tolerance test as described below, blood sam-
ples (0.3 µl) were obtained from human skin microvessels
using FreeStyle (Nipro, Osaka, Japan).
Oral glucose tolerance test (OGTT)
Healthy human volunteers (18–24 years old) were fasted
12 h before the starting point of experiments. The partici-
pants were perorally administered with either a suspen-
sion of green tea powder or hot water at 9:20 a.m. Ten min
after the administration (at 9:30 a.m.), the participants
were perorally administered with 225 ml of Trelan-G75
(Shimizu Pharmaceuticals Co., Shimizu, Shizuoka) con-
taining 75 g glucose. BGLs were measured before and 30,
60, and 120 min after the administration with Trelan-G75
(glucose). All the subjects enrolled in this study were eth-
nic Japanese. Before participation, the purpose and risks
of the study were carefully explained, and written
informed consent was obtained from all the participants.
The protocol was approved by the Toyama Medical and
Pharmaceutical University Ethics Committee regulating
human research.
Measurement of blood glucose levels and serum insulin 
levels
BGLs were measured using ANTSENSE II (Horiba, Kyoto,
Japan) in the mouse study and using FreeStyle (Nipro,
Osaka, Japan) in the human study. Serum insulin levels
were measured using an insulin-ELISA kit (Morinaga Seik-
agaku, Tokyo, Japan). To prepare the serum samples,
blood samples from mice (100 µl) were kept on ice for 2
h, centrifuged at 16,000 × g for 1 min at 4°C, and its
supernatant was immediately separated from the pellet.
SELDI ProteinChip Analysis
Quantitative serum proteomic profiles were measured
with SELDI-TOF-MS (Ciphergen Biosystems, Yokohama,
Japan). The mouse serum was prepared as described
above. Several types of ProteinChip Array, i.e., Q10 (an
anionic exchanger, pH8), CM10 (a cationic exchanger,
pH4 and pH7) and IMAC30-Cu2+ (immobilized metal
affinity chromatography, pH7) (Ciphergen Biosystems),
were used to fractionate proteins in serum. For the pro-
teomic analyses with Q10 ProteinChip array, samples
were 10-times diluted with denaturation buffer (7 M urea/
2 M Thiourea/ 4% CHAPS/ 1% dithiothreitol/ 2%
ampholine) and incubated on ice for 10 min, and then
10-times more diluted with buffer of 50 mM Tris-HCl
(pH8). When CM10 ProteinChip array was used, samples
were 10-times diluted with the denaturation buffer and
incubated on ice for 10 min, and then 10-times more
diluted with buffer of 100 mM NaOAc (pH4) or 50 mM
HEPES (pH7). When IMAC30 ProteinChip array was
used, samples were 100-times diluted with phophate-
buffered saline. Spots on the different arrays were equili-
brated with the buffer used for sample dilution, e.g., Tris-
HCl buffer for spots on Q10 array, and each sample solu-
tion (70 µl) was loaded onto two separate spots on the
arrays. After incubation for 20 min with rotation spots
were rinsed with water and air-dried completely. The
spots were analyzed using the SELDI ProteinChip system
(PBS-IIc, Ciphergen Biosystems). In each sample, data
from the two spots were averaged (duplicate assay). If a
signal/noise ratio was larger than 2, the peak was consid-
ered to reflect the amount of a protein. Quantitative
nature of the instrument was confirmed as previously
described [14]. The m/z value of each protein peak (the
molecular weight of each detected protein) was corrected,
based on the m/z values of the external standards of pep-
tides or proteins, the molecular weights of which are
known. Standard errors in the estimated molecular
weights were less than 0.1%. The axis of abscissa in spectra
(Figs 6B, 7B, 8 and 9) indicates the mass-to-charge ratio
(m/z) of protonated proteins.
Table 1: Contents of catechins and caffeine in green tea samples (grams per 100 g)
Green tea powder No. 12a No. 13b
catechins
C0 . 1 1 . 3 0
EC 0.6 1.9 1.0
ECg 0.6 1.6 0.2
EGC 0.3 0.9 5.8
EGCg 5.6 10.6 3.5
total 7.2 16.3 10.5
caffeine 4.3 4.5 1.7
C: (+)-catechin, EC: (-)-epicatechin, ECg: (-)-epicatechin gallate, EGC: (-)-epigallocatechin, EGCg: (-)-epigallocatechin gallate, total: total catechins. a,b 
The dried extract of fresh raw leaves of tea (Camellia sinensis, Theaceae) prepared at Cultivar No.12 (a, Chinhsuan) and No. 13 (b, Tzuiyu).BMC Pharmacology 2004, 4:18 http://www.biomedcentral.com/1471-2210/4/18
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Reagents
Fresh raw leaves of tea (Camellia sinensis, Theaceae) (Cul-
tivar No.12, Chinhsuan and No.13, Tzuiyu) were pre-
pared at the Taiwan Tea Experiment Station, picked in
May at Nan-Tou County, and immediately used without
drying. The leaves were steeped in hot water (95°C) for 30
min and the filtrate was condensed under reduced pres-
sure. The dry weight of the extracts was determined, and
the extracts were dissolved in saline for administration
into mice. On the other hand, green tea powder was
donated by Fukuju-en (Kyoto, Japan). The particle size
(median diameter) of the green tea powder was 2.9 µm,
according to the measurement using a Centrifugal Particle
Size Analyzer (Shimadzu, Kyoto, Japan). In the human
study, the tea powder (1.5 g) was added to 150 ml of hot
water (80°C) and then whipped with a bamboo whisk. In
the mouse study, the tea powder was suspended in saline
at room temperature using a sonicator. The contents of
caffeine and catechins in these tea samples were deter-
mined by HPLC: the samples were injected into an HPLC
column (TSK-GEL, ODS-80TM, Tosoh, Tokyo, Japan); the
eluent was 10 mM phosphate buffer (pH2.6)/MeCN
(gradient: 5 to 15%) at a flow rate of 1.3 ml/min. The data
are shown in Table 1.
Statistical analysis
The significance of differences between two groups was
assessed by Student's t-test, and the differences between
multiple groups were assessed by one-way analysis of
variance (ANOVA) followed by the Scheffé's multiple
range test. Values of P less than 0.05 were considered to be
significant. Especially, to determine the significance of the
time-dependent effects of green tea (Fig. 1 and 2) on the
blood glucose levels, repeated measures ANOVA was per-
formed, and then, if the statistical significance was
detected by this analysis, further statistical comparison at
each measurement time between the groups was con-
ducted by one-way ANOVA, followed by the Scheffé test.
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